Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
In 2019, Michael D. Story, PhD, vice chair of the Department of Radiation Oncology and chief of the Division of Molecular Radiation Biology at UT Southwestern Medical Center, was one of...
Guest post by Emil Lou, MD, PhD On October 7, 2020, the world awoke to news that the Royal...
Guest post by David Virshup, MD Singapore will hold its 12th Frontiers in Cancer Science (FCS) conference virtually Nov....
For October’s installment of Editors’ Picks, the AACR journal editors have selected studies that feature results from two phase...
The 2020 Nobel Prize in Chemistry was awarded to Fellows of the AACR Academy Emmanuelle Charpentier, PhD, and Jennifer A. Doudna, PhD, for their groundbreaking development of the CRISPR-Cas9 genome editing system. This technology allows researchers to accurately delete,...
Unlike cancer incidence rates overall, which are decreasing in the United States, the incidence rate of liver cancer has been increasing...
Emmanuelle Charpentier, PhD, and Jennifer A. Doudna, PhD, received the 2020 Nobel Prize in Chemistry last Wednesday, marking the third consecutive year in...
Immune checkpoint inhibition is a form of cancer immunotherapy that works by releasing the “brakes” on the immune system, thereby increasing...
As the coronavirus pandemic took root in the United States, many hospitals and cancer centers temporarily suspended treatments and...
In the United States, the rates of prostate cancer diagnosis and mortality have been steadily declining over the past decades, and...